Analysis of the genotypic profile and its relationship with the clinical manifestations in people with cystic fibrosis: study from a rare disease registry
Open Access
- 13 June 2022
- journal article
- research article
- Published by Springer Nature in Orphanet Journal of Rare Diseases
- Vol. 17 (1) , 1-11
Abstract
Cystic fibrosis (CF) has a vast and heterogeneous mutational spectrum in Europe. This variability has also been described in Spain, and there are numerous studies linking CFTR variants with the symptoms of the disease. Most of the studies analysed determinate clinical manifestations or specific sequence variants in patients from clinical units. Others used registry data without addressing the genotype–phenotype relationship. Therefore, the objective of this study is to describe the genetic and clinical characteristics of people with CF and to analyse the relationship between both using data from the rare disease registry of a region in southeastern Spain. A cross-sectional study was carried out in people with a confirmed diagnosis of CF registered in the Rare Diseases Information System (SIER) of the Region of Murcia (Spain). The patients were classified into two genotypes according to the functional consequence that the genetic variants had on the CFTR protein. There were 192 people diagnosed with CF reported in the Region of Murcia as of 31 December 2018. Seventy-six genotypes and 49 different variants were described, with c.1521_1523delCTT (p. Phe508del) being the most common in 58.3% of the CF patients and 37.0% of the alleles. In addition, 67% of the patients were classified as a high-risk genotype, which was associated with a lower percentage of FEV1 (OR: 5.3; 95% CI: 1.2, 24.4), an increased risk of colonization by Pseudomonas aeruginosa (OR: 7.5; 95% CI: 1.7, 33.0) and the presence of pancreatic insufficiency (OR: 28.1; 95% CI: 9.3, 84.4) compared to those with a low-risk genotype. This is the first study in Spain that describes the mutational spectrum and its association with clinical manifestations in patients with CF using data from a rare disease registry. The results obtained allow planning for the health resources needed by people with this disease, thus contributing to the development of personalized medicine that helps to optimize health care in CF patients.Keywords
All Related Versions
This publication has 49 references indexed in Scilit:
- Registro Español de Trasplante Pulmonar: primer informe de resultados (2006-2010)Archivos de Bronconeumología, 2013
- A CFTR Potentiator in Patients with Cystic Fibrosis and theG551DMutationNew England Journal of Medicine, 2011
- Type of CFTR Mutation Determines Risk of Pancreatitis in Patients With Cystic FibrosisGastroenterology, 2011
- Modifier genes in Mendelian disorders: the example of cystic fibrosisAnnals of the New York Academy of Sciences, 2010
- CFTR mutations in cystic fibrosis patients from Murcia region (southeastern Spain): implications for genetic testingClinical Genetics, 2009
- Consensus on the use and interpretation of cystic fibrosis mutation analysis in clinical practiceJournal of Cystic Fibrosis, 2008
- Spectrum of Mutations in the CFTR Gene in Cystic Fibrosis Patients of Spanish AncestryAnnals of Human Genetics, 2006
- Los registros de enfermedades en la investigación epidemiológica de las enfermedades raras en EspañaRevista Espanola de Salud Publica, 2006
- Cystic fibrosis: A worldwide analysis ofCFTR mutations?correlation with incidence data and application to screeningHuman Mutation, 2002
- Genotype-phenotype relationships in a cohort of adult cystic fibrosis patientsEuropean Respiratory Journal, 1996